Report Categories Report Categories

Report Categories

industry Category

All

Total: 5 records, 1 pages

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Supply, Demand and Key Producers, 2024-2030

date 21 Feb 2024

date Pharma & Healthcare

new_biaoQian PARP (Poly ADP-Ribose Polymerase) Inhibitor

The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size is expected to reach $ 8545.3 million by 2030, rising at a market growth of 8.5% CAGR during the forecast period (2024-2030).

USD4480.00

Add To Cart

Add To Cart

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 02 Jan 2024

date Pharma & Healthcare

new_biaoQian PARP (Poly ADP-Ribose Polymerase) Inhibitor

According to our (Global Info Research) latest study, the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size was valued at USD 4822.1 million in 2023 and is forecast to a readjusted size of USD 8545.3 million by 2030 with a CAGR of 8.5% during review period.

USD3480.00

Add To Cart

Add To Cart

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 18 Mar 2023

date Pharma & Healthcare

new_biaoQian PARP (Poly ADP-Ribose Polymerase) Inhibitor

PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).

USD3480.00

Add To Cart

Add To Cart

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

date 04 Jan 2022

date Pharma & Healthcare

new_biaoQian parp poly adp ribose polymerase inhibitor

The PARP (Poly ADP-Ribose Polymerase) Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

Add To Cart

Add To Cart

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

date 12 Sep 2021

date Pharma & Healthcare

new_biaoQian parp poly adp ribose polymerase inhibitor

The PARP (Poly ADP-Ribose Polymerase) Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

Add To Cart

Add To Cart

industry 21 Feb 2024

industry Pharma & Healthcare

new_biaoQian PARP (Poly ADP-Ribose Polymerase) Inhibitor

The global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size is expected to reach $ 8545.3 million by 2030, rising at a market growth of 8.5% CAGR during the forecast period (2024-2030).

USD4480.00

addToCart

Add To Cart

industry 02 Jan 2024

industry Pharma & Healthcare

new_biaoQian PARP (Poly ADP-Ribose Polymerase) Inhibitor

According to our (Global Info Research) latest study, the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size was valued at USD 4822.1 million in 2023 and is forecast to a readjusted size of USD 8545.3 million by 2030 with a CAGR of 8.5% during review period.

USD3480.00

addToCart

Add To Cart

industry 18 Mar 2023

industry Pharma & Healthcare

new_biaoQian PARP (Poly ADP-Ribose Polymerase) Inhibitor

PARP inhibitors are a group of pharmacological inhibitors of the enzyme poly ADP ribose polymerase (PARP).

USD3480.00

addToCart

Add To Cart

industry 04 Jan 2022

industry Pharma & Healthcare

new_biaoQian parp poly adp ribose polymerase inhibitor

The PARP (Poly ADP-Ribose Polymerase) Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

addToCart

Add To Cart

industry 12 Sep 2021

industry Pharma & Healthcare

new_biaoQian parp poly adp ribose polymerase inhibitor

The PARP (Poly ADP-Ribose Polymerase) Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

USD3480.00

addToCart

Add To Cart